Perceptive Advisors’s Lineage Cell Therapeutics LCTX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q1
Sell
-7,236,843
Closed -$3.64M 97
2024
Q4
$3.64M Buy
+7,236,843
New +$3.64M 0.1% 76
2016
Q3
Sell
-15,705
Closed -$36K 204
2016
Q2
$36K Buy
+15,705
New +$36K ﹤0.01% 153